Auxly Cannabis Group Crecimiento futuro

Future controles de criterios 0/6

Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de Auxly Cannabis Group.

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Pharmaceuticals	57.6%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	None
Última actualización	n/a

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Does Auxly Cannabis Group (TSE:XLY) Have A Healthy Balance Sheet?

Apr 27

A Piece Of The Puzzle Missing From Auxly Cannabis Group Inc.'s (TSE:XLY) 33% Share Price Climb

Mar 21

Auxly Cannabis Group Inc. (TSE:XLY) Stock Rockets 33% But Many Are Still Ignoring The Company

Feb 03

Take Care Before Jumping Onto Auxly Cannabis Group Inc. (TSE:XLY) Even Though It's 38% Cheaper

Dec 19

The Consensus EPS Estimates For Auxly Cannabis Group Inc. (TSE:XLY) Just Fell Dramatically

Aug 11

Health Check: How Prudently Does Auxly Cannabis Group (TSE:XLY) Use Debt?

Jul 21

Growth Investors: Industry Analysts Just Upgraded Their Auxly Cannabis Group Inc. (TSE:XLY) Revenue Forecasts By 8.2%

Aug 18

Auxly Cannabis Group Inc. (TSE:XLY) Just Reported And Analysts Have Been Cutting Their Estimates

Apr 29

Breakeven On The Horizon For Auxly Cannabis Group Inc. (CVE:XLY)

Mar 24

A Look At Auxly Cannabis Group's (CVE:XLY) Share Price Returns

Jan 28

En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como Auxly Cannabis Group no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.

Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.

Previsiones de crecimiento de beneficios e ingresos

TSX:XLY - Estimaciones futuras de los analistas y datos financieros pasados (CAD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2023	101	-45	7	8	N/A
9/30/2023	99	-7	0	6	N/A
6/30/2023	90	-99	-8	1	N/A
3/31/2023	96	-101	-1	8	N/A
12/31/2022	94	-130	-12	-2	N/A
9/30/2022	99	-133	-21	-22	N/A
6/30/2022	104	-86	-23	-26	N/A
3/31/2022	97	-75	-38	-38	N/A
12/31/2021	84	-46	-50	-50	N/A
9/30/2021	73	-53	-51	-44	N/A
6/30/2021	61	-57	-57	-43	N/A
3/31/2021	46	-81	-53	-39	N/A
12/31/2020	47	-84	-54	-33	N/A
9/30/2020	32	-116	-82	-52	N/A
6/30/2020	21	-115	-93	-59	N/A
3/31/2020	17	-102	-109	-73	N/A
12/31/2019	8	-103	-113	-79	N/A
9/30/2019	5	-80	-89	-71	N/A
6/30/2019	4	-72	-87	-66	N/A
3/31/2019	1	-70	-78	-55	N/A
12/31/2018	1	-67	-61	-44	N/A
9/30/2018	2	-41	-42	-29	N/A
6/30/2018	2	-38	-33	-25	N/A
3/31/2018	3	-27	-19	-18	N/A
12/31/2017	2	-18	-12	-11	N/A
9/30/2017	0	-9	N/A	-9	N/A
6/30/2017	0	-3	N/A	-3	N/A
3/31/2017	0	-2	N/A	-1	N/A
12/31/2016	0	0	N/A	0	N/A
9/30/2016	0	0	N/A	0	N/A
6/30/2016	0	0	N/A	0	N/A
3/31/2016	0	0	N/A	0	N/A
12/31/2015	0	0	N/A	0	N/A
9/30/2015	0	0	N/A	0	N/A
6/30/2015	0	0	N/A	0	N/A
3/31/2015	0	0	N/A	0	N/A
12/31/2014	0	0	N/A	0	N/A
9/30/2014	0	0	N/A	0	N/A
6/30/2014	0	0	N/A	0	N/A
3/31/2014	0	0	N/A	0	N/A
12/31/2013	0	0	N/A	0	N/A
9/30/2013	0	0	N/A	0	N/A
6/30/2013	0	0	N/A	0	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de XLY es superior a la tasa de ahorro (2%).

Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de XLY crezcan más rápidamente que el mercado Canadian

Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de XLY crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de XLY crezcan más rápidamente que el mercado de Canadian.

Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de XLY crezcan a un ritmo superior a 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de XLY se prevé que sea elevada dentro de 3 años.

Auxly Cannabis Group Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Consensus EPS estimates fall by 47%

Consensus revenue estimates fall by 11%

Consensus EPS estimates fall by 12%

Consensus revenue estimates fall by 15%

Price target decreased to CA$0.41

Price target increased to CA$0.55

Recent updates

Does Auxly Cannabis Group (TSE:XLY) Have A Healthy Balance Sheet?

Auxly Cannabis Group Inc., Annual General Meeting, Jun 28, 2024

New minor risk - Shareholder dilution

Full year 2023 earnings released: CA$0.045 loss per share (vs CA$0.15 loss in FY 2022)

A Piece Of The Puzzle Missing From Auxly Cannabis Group Inc.'s (TSE:XLY) 33% Share Price Climb

Auxly Cannabis Group Inc. to Report Q4, 2023 Results on Mar 25, 2024

Auxly Cannabis Group Inc. (TSE:XLY) Stock Rockets 33% But Many Are Still Ignoring The Company

Take Care Before Jumping Onto Auxly Cannabis Group Inc. (TSE:XLY) Even Though It's 38% Cheaper

Third quarter 2023 earnings released: EPS: CA$0.033 (vs CA$0.067 loss in 3Q 2022)

Auxly Cannabis Group Inc. to Report Q3, 2023 Results on Nov 13, 2023

Insufficient new directors

New major risk - Market cap size

Does Auxly Cannabis Group (TSE:XLY) Have A Healthy Balance Sheet?

New major risk - Financial position

Second quarter 2023 earnings released: CA$0.013 loss per share (vs CA$0.016 loss in 2Q 2022)

Auxly Cannabis Group Inc. to Report Q2, 2023 Results on Aug 14, 2023

Auxly Cannabis Group Inc. Announces Executive Changes

Is Auxly Cannabis Group (TSE:XLY) Using Debt In A Risky Way?

First quarter 2023 earnings released: CA$0.011 loss per share (vs CA$0.047 loss in 1Q 2022)

Auxly Cannabis Group Inc. to Report Q1, 2023 Results on May 15, 2023

Auxly Cannabis Group Inc. (TSE:XLY) Could Be Riskier Than It Looks

Full year 2022 earnings released: CA$0.15 loss per share (vs CA$0.059 loss in FY 2021)

Auxly Cannabis Group Inc. announced that it has received CAD 3.36 million in funding

Auxly Cannabis Group Inc. announced that it expects to receive CAD 3.36 million in funding

Morganti & Co. Issues Auxly Cannabis Group, Inc. Shareholder Class Action Notice of Certification

Consensus EPS estimates fall by 47%

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Auxly Cannabis Group Inc. to Report Q3, 2022 Results on Nov 14, 2022

Second quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

The Consensus EPS Estimates For Auxly Cannabis Group Inc. (TSE:XLY) Just Fell Dramatically

An unknown buyer acquired Outdoor cultivation facility located in Hortonville, Nova Scotia from Auxly Cannabis Group Inc. (TSX:XLY) for CAD 4.1 million.

Consensus revenue estimates fall by 11%

Auxly Cannabis Group Inc. to Report Q2, 2022 Results on Aug 15, 2022

Auxly Cannabis Group Inc. Introduces Edi's by Foray with the Launch of Large-Pack, Snackable Edibles

Consensus EPS estimates fall by 12%

Health Check: How Prudently Does Auxly Cannabis Group (TSE:XLY) Use Debt?

An unknown buyer acquired Auxly Annapolis Inc from Auxly Cannabis Group Inc. (TSX:XLY) for CAD 6 million.

Consensus revenue estimates fall by 15%

Auxly Cannabis Group Inc. Reports Impairment Changes for the First Quarter Ended March 31, 2022

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Auxly Cannabis Group Inc. to Report Q1, 2022 Results on May 16, 2022

Price target decreased to CA$0.41

Auxly Cannabis Group Inc., Annual General Meeting, Jun 30, 2022

Auxly Cannabis Group Inc. Announces Close of Robinsons Cultivation Facilities

KSM Securities Litigation Group Announces Ontario Court Grants Leave to Shareholders to Advance Statutory Claim Against Auxly Cannabis Securities Class Action

Price target increased to CA$0.55

Forecast to breakeven in 2024

Auxly Cannabis Group Inc. (TSX:XLY) acquired Sunens Farms Inc. from Peter Quiring for CAD 5 million.

Price target decreased to CA$0.51

Third quarter 2021 earnings released: CA$0.016 loss per share (vs CA$0.028 loss in 3Q 2020)

Price target increased to CA$0.50

Second quarter 2021 earnings released: CA$0.005 loss per share (vs CA$0.046 loss in 2Q 2020)

Growth Investors: Industry Analysts Just Upgraded Their Auxly Cannabis Group Inc. (TSE:XLY) Revenue Forecasts By 8.2%

Consensus forecasts updated

Auxly Cannabis Group Inc. on Hot Streak Heading into Summer Packed with New Products

Auxly Cannabis Group Inc. has completed a Composite Units Offering in the amount of CAD 15.0003 million.

CEO & Director recently bought CA$169k worth of stock

Consensus EPS estimates fall to -CA$0.05

Myconic Capital Corp. (DB:MY0) completed the acquisition of KGK Science Inc. from Auxly Cannabis Group Inc. (TSX:XLY).

Price target decreased to CA$0.52

Myconic Capital Corp. (DB:MY0) entered into a definitive share purchase agreement to acquire KGK Science Inc. from Auxly Cannabis Group Inc. (TSX:XLY) for CAD 16.5 million.

First quarter 2021 earnings released: CA$0.015 loss per share (vs CA$0.02 loss in 1Q 2020)

Auxly Cannabis Group Inc. announced that it has received CAD 8 million in funding

Auxly Cannabis Group Inc. announced that it expects to receive CAD 8 million in funding

Auxly Cannabis Group Inc. (TSE:XLY) Just Reported And Analysts Have Been Cutting Their Estimates

Full year 2020 earnings released: CA$0.14 loss per share (vs CA$0.17 loss in FY 2019)

Breakeven On The Horizon For Auxly Cannabis Group Inc. (CVE:XLY)

Auxly Cannabis Group Inc. Announces Strategic Expansion into Cannabis 1.0

Namaste Technologies Announces Expansion of Product Range to Canadian Medical Customers at CannMart.com with the Addition of Leading Licensed Producers Including Auxly and TGOD